High-energy lower-extremity trauma (HELET) is common in modern warfare, often resulting in severe tissue damage, chronic pain, neurovascular injury and significant muscle loss, according to the new research presented today ...
Mar 19, 2013
0
0
The popular half-gloves that leave fingers uncovered for texting may be good for communicating electronically, but they may also lead to permanent loss of fingers due to exposure to the cold.
Feb 28, 2013
0
0
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Feb 15, 2013
0
0
Every 30 seconds somebody in the world is amputated as a consequence of foot complication due to diabetes. A new study at Sahlgrenska Academy, University of Gothenburg, Sweden, confirmes that shoe inserts, podiatry, regular ...
Jan 17, 2013
0
0
(Medical Xpress)—In a new study published in the scientific journal Circulation, scientists at Karolinska Institutet and Karolinska University Hospital show that an enzyme called arginase might have a key part to play in ...
Nov 27, 2012
0
0
(AP)—Zac Vawter considers himself a test pilot. After losing his right leg in a motorcycle accident, the 31-year-old software engineer signed up to become a research subject, helping to test a trailblazing prosthetic leg ...
Oct 31, 2012
0
0
Restoring diminished levels of a protein shown to prevent and reverse heart failure damage could also have therapeutic applications for patients with critical limb ischemia (CLI), suggests a new preclinical study published ...
Oct 10, 2012
0
0
(Medical Xpress)—People with diabetes who develop foot ulcers are at more risk of dying prematurely than those without the complication, finds a new large-scale study. The researchers say the findings highlight the potential ...
Oct 10, 2012
0
0
(HealthDay)—In Scotland, from 2004 to 2008, the incidence of all lower-extremity amputations (LEAs) due to diabetes was significantly reduced by about 30 percent, and the rate of major LEAs was reduced by about 40 percent, ...
Oct 4, 2012
0
0
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...
Sep 21, 2012
0
0
